학술논문
Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial.
Document Type
Correction Notice
Author
Source
Subject
*GENETIC mutation
*HER2 gene
*CLINICAL trials
*
*
Language
ISSN
0923-7534